Dr Kathryn Musgrave Dr Jonathan Scott Dr Wezi Sendama Aaron Gardner Fiona Dewar et al. | Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis | 2023 |
|
Dr Kathryn Musgrave Jonathan Scott Dr Wezi Sendama Dr Patrick Kesteven Dr Marie-Helene Ruchaud et al. | The differential surface expression of tissue factor between monocyte subsets | 2020 |
|
Salah Abohelaika Dr Hilary Wynne Dr Peter Avery Dr Patrick Kesteven Professor Farhad Kamali et al. | Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management | 2016 |
|
Dr Kate Musgrave Professor John Simpson Dr Patrick Kesteven
| Is there any clinical or biological difference that distinguishes recurrence from non-recurrence after idiopathic PE? | 2016 |
|
Dr Patrick Kesteven
| The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry | 2015 |
|
Salah Abohelaika Professor Farhad Kamali Dr Peter Avery Dr Patrick Kesteven Dr Hilary Wynne et al. | Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England | 2014 |
|
Basav Sen Dr Patrick Kesteven Dr Peter Avery
| Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED) | 2014 |
|
Dr Patrick Kesteven Professor Ann Daly Dr Peter Avery Professor Farhad Kamali
| A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study | 2013 |
|
Dr Patrick Kesteven Julian Leathart Professor Ann Daly Professor Farhad Kamali
| A Randomized Trial of Genotype-Guided Dosing of Warfarin | 2013 |
|
Professor Farhad Kamali Dr Hilary Wynne Dr Patrick Kesteven Dr John Hanley Dr Jing Shen et al. | Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K | 2013 |
|
Dr Logan Thirugnanasothy Dr Patrick Kesteven Professor John Dark
| Pulmonary embolism: Surgical embolectomy is underused | 2013 |
|
Dr Arun Natarajan Emerita Professor Sally Marshall Dr Patrick Kesteven Dr Janet McComb
| Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes | 2011 |
|
Mohamed Noormohamed Susan Stamp Dr Brian Shenton Dr Patrick Kesteven Dr Noel Carter et al. | Effects of extra corporeal membrane oxygenation (ECMO) on liver function and histology, in a porcine model of uncontrolled non heart beating donor (NHBD) | 2010 |
|
Dr Montserrat Briz Del Blanco Dr Katherine Talks Dr John Hanley Dr Patrick Kesteven Professor Ann Daly et al. | Reversal of warfarin-induced over-anticoagulation with individualized dosing of oral vitamin K: a pilot study | 2010 |
|
Dr Katherine Talks Dr John Hanley Dr Patrick Kesteven Dr Peter Avery Professor Ann Daly et al. | Individualised oral vitamin K for reversal of warfarin excessive anticoagulation | 2009 |
|
Dr Jonathan Smout Dr Alexander Dyker Professor Gary Ford Dr Patrick Kesteven Professor Gerard Stansby et al. | Platelet Function Following Acute Cerebral Ischemia | 2009 |
|
Dr Patrick Kesteven Dr Katherine Talks Dr John Hanley
| A retrospective audit of a standard protocol for the rapid reversal of warfarin in patients with intracranial haemorrhage | 2007 |
|
Dr Patrick Kesteven
| Early discharge of patients with pulmonary embolism: a two-phase observational study | 2007 |
|
Dr Brian Angus Dr Patrick Kesteven
| Localized reactive angioendotheliomatosis | 2007 |
|
Sheryl Mitchell Elizabeth Lingard Dr Patrick Kesteven Professor Andrew McCaskie Craig Gerrand et al. | Venous Thromboembolism in Patients with Primary Bone or Soft-Tissue Sarcomas | 2007 |
|
Wei Zhang Dr Patrick Kesteven
| Which patients with venous thrombosis do not require screening for malignancy? A predictive model to identify patients with VTE at minimal risk of malignancy | 2007 |
|
James McCaslin Dr Jonathan Smout Dr Patrick Kesteven Professor Gerard Stansby
| Oral antiplatelet agents and bleeding risk in relation to major cardiovascular surgery | 2006 |
|
Dr Patrick Kesteven
| Outpatient management of pulmonary embolism: results from the national Multicentre PE study | 2006 |
|
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Patrick Kesteven Dr Peter Avery et al. | [abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements | 2005 |
|
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Barry King et al. | The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen | 2005 |
|
John Hamilton Dr Jon Smith Dr Jonathan Wallis Dr Patrick Kesteven Dr John O'Sullivan et al. | ABO-incompatible heart transplantation in infants: The Freeman Hospital experience | 2004 |
|
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Dr Patrick Kesteven Peter Wood et al. | Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin | 2004 |
|
Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Patrick Kesteven Professor Farhad Kamali et al. | Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin | 2004 |
|
Dr Jonathan Smout Dr Alexander Dyker Dr Patrick Kesteven Professor Gerard Stansby
| Do soluble and platelet surface P-selectin levels correlate with conventional markers of platelet activation? | 2004 |
|
Dr Tayyaba Khan Professor Farhad Kamali Dr Patrick Kesteven Dr Peter Avery Dr Hilary Wynne et al. | The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation | 2004 |
|
Dr Patrick Kesteven
| A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation | 2003 |
|
Dr Patrick Kesteven Ritu Arya
| Long haul flights and deep vein thrombosis: Who is at risk? | 2003 |
|
Dr Hilary Wynne Dr Patrick Kesteven Professor Farhad Kamali
| The impact of stability of oral anticoagulant therapy upon patient perceived health status and quality of life | 2003 |
|
Dr Patrick Kesteven
| Incidence of symptomatic thrombosis in a stable population of 650,000: Travel and other risk factors | 2002 |
|
Dr Janet McComb Dr Patrick Kesteven Emerita Professor Sally Marshall
| QT prolongation in patients with Type 2 diabetes and microalbuminuria | 2002 |
|
Dr Patrick Kesteven
| The role of strain gauge plethysmography in the assessment of patients with suspected deep vein thrombosis | 2002 |
|
Dr Patrick Kesteven
| Clinical risk factors for venous thrombosis associated with air travel | 2001 |
|
Dr Ahmed Chishti Professor John Dark Dr Patrick Kesteven Dr Hazel Powell Dr Christopher Snowden et al. | Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass | 2001 |
|
Dr Patrick Kesteven Dr Peter Saunders
| Model for assessment of endothelial cell function and viability using the MTT dye test and [3H] | 2001 |
|
Dr Patrick Kesteven
| Superficial thrombophlebitis followed by pulmonary embolism | 2001 |
|
Professor Farhad Kamali Dr Hilary Wynne Dr Patrick Kesteven
| Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans | 2001 |
|
Dr Akif Gani Dr Patrick Kesteven Dr Richard Lendrum
| Aortic stenosis and bleeding from angiodysplasia in elderly patients: Is acquired Von Willebrand's disease the link | 1999 |
|
Professor Chris Day Dr Patrick Kesteven Professor Ann Daly
| Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications | 1999 |
|
Dr Janet McComb Dr Patrick Kesteven Emerita Professor Sally Marshall Professor Graham Jackson
| Endothelial dysfunction, disordered coagulation and fibrinolysis in patients with type 2 diabetes and microalbuminuria | 1999 |
|
Dr Patrick Kesteven Dr Janet McComb Emerita Professor Sally Marshall
| Reduced ankle brachial index is strongly linked to albumin excretion rate and white cell count but not to measures of endothelial dysfunction or coagulation in NIDDM | 1999 |
|
Professor Chris Day Dr Patrick Kesteven Professor Ann Daly
| Warfarin dose requirement and CYP2C9 polymorphisms - Reply | 1999 |
|